[One year's experience with pilocarpin-ocusert in the therapy of glaucoma (author's transl)].
The authors report on their own treatment results with the drug carrier Ocusert (Federal Rep. of Germany: Chemie Grunenthal). Furthermore the effect on the IOP and the compatibility including the accomodative myopia is discussed. The effect on IOP was approximately equal to Pilocarpine 2% four times daily. The accommodation myopia was significanly less than using Pilocarpin drops. A short time after insertion the conjuntiva was irritated but the irritation faded within a short time.
D002986:Clinical Trials as Topic; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D009216:Myopia / Q000139:chemically induced; D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles / Q000009:adverse effects / Q000592:standards; D010862:Pilocarpine / Q000008:administration & dosage* / Q000009:adverse effects
D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles; D010862:Pilocarpine
Ein Jahr Erfahrungen mit Pilocarpin-Ocusert in der Glaukombehandlung